Delivery Order SPE2DB22D1017-SPE2DB25FF2WG

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xarelto 20 mg tablets. The fixed-price, delivery order contract has a ceiling value of $9,751.15 and a period of performance running through November 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,572.81 firm fixed-price delivery order is for the supply of Xarelto 20 mg tablets. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $11,469.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xarelto 20 mg tablets, a cardiovascular medication, with a completion date of September 22, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,443.49 firm-fixed-price delivery order is for 4,567,011,690 units of the pharmaceutical drug Xarelto 20 mg tablets. The award has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xarelto 20 mg tablets. The $7,116.73 firm fixed price delivery order has a completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xarelto 20 mg tablets. The contract has a ceiling value of $11,793.63 and runs through November 13, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Xarelto 20mg tablets to the U.S. government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,514.97 firm fixed price contract is for the supply of Xarelto 20 mg tablets. The ultimate completion date is October 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $18,652.35 for the supply of Xarelto 20 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of September 13, 2024. The contract is a Firm Fixed Price type without any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award, valued at $6,795.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Xarelto 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of January 18, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2WG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20mg tablets. The contract, valued at $15,708.57, is a delivery order with a firm fixed price. It has an ultimate completion date of January 13, 2025. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:33 AM